The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Based on an Apple study, researchers have developed a free asthma management tool, now available as an app, or on the web.
Millions of Brits live with asthma and rely on a variety of treatments to manage their condition, but a new study has raised ...
Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...
From morning workouts to household cleaning, discover how common daily activities could trigger severe asthma attacks in ...
Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.
Blue Cross Blue Shield — which covers more than 10 million Texans — intends to slash coverage for several asthma therapies injected into the bloodstream under the supervision of a physician. Many ...
Managing asthma properly requires routine physician visits, taking medications as directed and paying attention to asthma ...
Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results